NCT07305090 Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut Status RECRUITING Phase N/A
NCT07148180 A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax Status RECRUITING Phase PHASE1/PHASE2
NCT07052916 A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties Status RECRUITING Phase NA
NCT06904066 Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies Status RECRUITING Phase PHASE1
NCT06817759 Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer Status NOT_YET_RECRUITING Phase NA
NCT06645132 Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant. Status ACTIVE_NOT_RECRUITING Phase NA
NCT06582849 Enhanced Assistance During Radiotherapy for Unmet Essential Needs Status COMPLETED Phase NA
NCT06574308 Clinical Evaluation of the Scopio Cell Morphology Technology Status NOT_YET_RECRUITING Phase N/A
NCT06543511 MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies Status WITHDRAWN Phase NA
NCT06510699 Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial Status RECRUITING Phase PHASE2
NCT06482515 Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue Status RECRUITING Phase PHASE2
NCT06469307 Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) Status RECRUITING Phase NA
NCT06455592 Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years Status RECRUITING Phase NA
NCT06168825 Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention Status COMPLETED Phase N/A
NCT06119685 IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT05873205 Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05709522 Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients Status UNKNOWN Phase N/A
NCT05692713 Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) Status RECRUITING Phase N/A